Navigation Links
Atrium Responds to Bard Suit
Date:8/17/2010

HUDSON, N.H., Aug. 18 /PRNewswire/ -- Atrium Medical Corporation was recently named as a defendant, along with Endologix, Inc., of Irvine, CA, in a lawsuit brought by C.R. Bard in U.S. District Court in Arizona.  The suit involves a patent, U.S. No. 6,436,135, issued to Bard in 2002 related to prosthetic vascular grafts made of ePTFE (expanded polytetrafluoroethylene). Atrium has been involved in discussions with Bard management regarding this patent for several years.

The patent was filed in 1974 and has been the subject almost continuous litigation for nearly thirty years between Bard and W. L. Gore Associates before the U.S. Patent Office and the courts. That litigation is still ongoing, and involves questions about the validity and scope of the patent that will ultimately have to be resolved by the court of appeals. Final resolution, however, will take upwards of two years or more.

Steve Herweck, Chairman and Chief Executive Officer of Atrium, said, "Atrium's management has every intention to resolve this issue in the best interest of our firm, employees and shareholders. Atrium remains committed to our almost 30 year history and practice of not knowingly violating anyone's intellectual property. Litigation by many companies today has unfortunately become an integral and daily part of business practice by many, including those in the diverse healthcare industry. We remain confident in attaining a resolution to this suit filed by Bard, and remain steadfast in our commitment to uninterrupted supply of all of our products, and our legacy of the 'best-in-the-industry' customer service to our customers."

Endologix also responded to the suit in a statement last week, saying it was confident its products do not infringe Bard's patent.

About Atrium

Founded in 1981, Atrium is a diversified healthcare provider dedicated to innovation, research and development, state-of-the-art manufacturing, customer service, and clinical education. From the cardiac cath-lab to the operating room, Atrium offers a diversified portfolio of critical care products leading the way to brighter, more clinically effective solutions in cardiovascular disease, soft tissue repair and critical care management.


'/>"/>
SOURCE Atrium Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
2. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
3. Roche responds to announcement of IDEAL hepatitis C trial results
4. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
5. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
6. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
7. EPSScentral Responds to Pandemic Alert
8. Endologix Responds to Alleged Patent Infringement
9. U.S. Kidney Dialysis Community Responds to Haitis Emergency Plea for Life-Saving Dialysis Care
10. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
11. Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... 2, 2016 On Thursday, December ... excellence in research, development and innovation in the biopharmaceutical ... was held in the presence of Sergey Tsyb, Vice ... Russian Federation , Natalia Sanina, First Vice Chairman ... , Head of Roszdravnadzor, National Service of Control in ...
(Date:12/2/2016)... -- bioLytical Laboratories, ein Weltführer bei schnellen Tests für Infektionskrankheiten, ... von Kenia eingeführt. Continue Reading ... ... (PRNewsFoto/bioLytical Laboratories) ... http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical wurde durch die Clinton ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... edition of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic ... health while maintaining fulfilling lives. “We are prolonging life 6 years in the ...
(Date:12/2/2016)... ... 2016 , ... Sourced from the Isbre Springs beneath the 5,000 year old ... purity of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent ... in several ShopRite and FoodTown stores in NJ and received rave comments from consumers. ...
(Date:12/2/2016)... San Francisco, CA (PRWEB) , ... December 02, ... ... in digitally-enabled care journeys, announced today that it has raised $6.0 million in ... are inspired by Clarify Health’s conviction that patients and their caregivers can receive ...
(Date:12/2/2016)... ... 2016 , ... ‘Tis the season for giving! Today, 20 creative teams across ... Partnership and the Drug Enforcement Administration as part of the National Red Ribbon Week ... schools who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. Be ...
(Date:11/30/2016)... ... 30, 2016 , ... Standard Process, Inc. is proud to ... recognition of the largest closely held companies headquartered in Wisconsin. This marks the ... Standard Process was awarded the Talent Award for providing outstanding employee benefits. ...
Breaking Medicine News(10 mins):